INS and infection: While individuals with healthy metabolic function may compensate through increased insulin secretion, those with predisposing factors such as obesity or baseline insulin resistance face a significantly heightened risk of sustained hyperglycemia and the onset of DM due to the combined metabolic strain of infection and treatment [116].